Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)

Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) — VMCI valuation read

000908.SZ screens at VMCI 41/100, a 10-point gap below the Healthcare sector median (50). For a mid-cap Hunan Jingfeng Pharmaceutical Co.,Ltd. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

000908.SZ has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 000908.SZ trades at 26.0x earnings, 44% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 0.0x leaves covenant headroom, which sets the rate-cycle exposure for Hunan Jingfeng Pharmaceutical Co.,Ltd..

000908.SZ fell 2.0% over the trailing 7 days, with a +4.8% read on a 30-day basis.